Vanda Pharmaceuticals VNDA

$ 7.0 -1.41%

Annual report 2025
added 02-12-2026

Vanda Pharmaceuticals DIO Ratio 2011-2026 | VNDA

Annual DIO Ratio Vanda Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
50.1	49.7	31.5	16.7	16.4	18.9	17	17.7	17.2	11.5	20.1	1.13 K	-	161	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.13 K	11.5	120

Quarterly DIO Ratio Vanda Pharmaceuticals

2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
68.2	47.3	-	55.1	-	-	-	31.1	28.5	22	-	11.5	9.71	18.6	-	13.1	16.8	20	-	19.8	20	21.2	-	15.3	16.3	19	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
68.2	9.71	25.2

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Cerus Corporation CERS	213	$ 2.72	33.99 %	$ 518 M	USA
	ACADIA Pharmaceuticals ACAD	295	$ 21.95	-2.23 %	$ 3.64 B	USA
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
	Berkeley Lights BLI	246	-	-7.31 %	$ 87 M	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Caladrius Biosciences CLBS	35.8	-	-16.75 %	$ 25.8 M	USA
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Deciphera Pharmaceuticals DCPH	2.04 K	-	-	$ 2.18 B	USA
	Dynavax Technologies Corporation DVAX	455	-	-	$ 2.02 B	USA
	Edesa Biotech EDSA	184	$ 17.59	-3.75 %	$ 56.2 M	USA
	Eiger BioPharmaceuticals EIGR	33.5 K	-	-9.21 %	$ 2.55 M	USA